Cargando…

Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology

Myelin disruption is a feature of natural aging and Alzheimer’s disease (AD). In the CNS, myelin is produced by oligodendrocytes, which are generated throughout life by oligodendrocyte progenitor cells (OPCs). Here, we examined age-related changes in OPCs in APP/PS1 mice, a model for AD-like patholo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chacon-De-La-Rocha, Irene, Fryatt, Gemma, Rivera, Andrea D., Verkhratsky, Alexei, Raineteau, Olivier, Gomez-Nicola, Diego, Butt, Arthur M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744306/
https://www.ncbi.nlm.nih.gov/pubmed/33343301
http://dx.doi.org/10.3389/fncel.2020.575082
_version_ 1783624409524731904
author Chacon-De-La-Rocha, Irene
Fryatt, Gemma
Rivera, Andrea D.
Verkhratsky, Alexei
Raineteau, Olivier
Gomez-Nicola, Diego
Butt, Arthur M.
author_facet Chacon-De-La-Rocha, Irene
Fryatt, Gemma
Rivera, Andrea D.
Verkhratsky, Alexei
Raineteau, Olivier
Gomez-Nicola, Diego
Butt, Arthur M.
author_sort Chacon-De-La-Rocha, Irene
collection PubMed
description Myelin disruption is a feature of natural aging and Alzheimer’s disease (AD). In the CNS, myelin is produced by oligodendrocytes, which are generated throughout life by oligodendrocyte progenitor cells (OPCs). Here, we examined age-related changes in OPCs in APP/PS1 mice, a model for AD-like pathology, compared with non-transgenic (Tg) age-matched controls. The analysis was performed in the CA1 area of the hippocampus following immunolabeling for NG2 with the nuclear dye Hoescht, to identify OPC and OPC sister cells, a measure of OPC replication. The results indicate a significant decrease in the number of OPCs at 9 months in APP/PS1 mice, compared to age-matched controls, without further decline at 14 months. Also, the number of OPC sister cells declined significantly at 14 months in APP/PS1 mice, which was not observed in age-matched controls. Notably, OPCs also displayed marked morphological changes at 14 months in APP/PS1 mice, characterized by an overall shrinkage of OPC process domains and increased process branching. The results indicate that OPC disruption is a pathological sign in the APP/PS1 mouse model of AD.
format Online
Article
Text
id pubmed-7744306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77443062020-12-18 Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology Chacon-De-La-Rocha, Irene Fryatt, Gemma Rivera, Andrea D. Verkhratsky, Alexei Raineteau, Olivier Gomez-Nicola, Diego Butt, Arthur M. Front Cell Neurosci Cellular Neuroscience Myelin disruption is a feature of natural aging and Alzheimer’s disease (AD). In the CNS, myelin is produced by oligodendrocytes, which are generated throughout life by oligodendrocyte progenitor cells (OPCs). Here, we examined age-related changes in OPCs in APP/PS1 mice, a model for AD-like pathology, compared with non-transgenic (Tg) age-matched controls. The analysis was performed in the CA1 area of the hippocampus following immunolabeling for NG2 with the nuclear dye Hoescht, to identify OPC and OPC sister cells, a measure of OPC replication. The results indicate a significant decrease in the number of OPCs at 9 months in APP/PS1 mice, compared to age-matched controls, without further decline at 14 months. Also, the number of OPC sister cells declined significantly at 14 months in APP/PS1 mice, which was not observed in age-matched controls. Notably, OPCs also displayed marked morphological changes at 14 months in APP/PS1 mice, characterized by an overall shrinkage of OPC process domains and increased process branching. The results indicate that OPC disruption is a pathological sign in the APP/PS1 mouse model of AD. Frontiers Media S.A. 2020-12-03 /pmc/articles/PMC7744306/ /pubmed/33343301 http://dx.doi.org/10.3389/fncel.2020.575082 Text en Copyright © 2020 Chacon-De-La-Rocha, Fryatt, Rivera, Verkhratsky, Raineteau, Gomez-Nicola and Butt. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular Neuroscience
Chacon-De-La-Rocha, Irene
Fryatt, Gemma
Rivera, Andrea D.
Verkhratsky, Alexei
Raineteau, Olivier
Gomez-Nicola, Diego
Butt, Arthur M.
Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
title Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
title_full Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
title_fullStr Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
title_full_unstemmed Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
title_short Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
title_sort accelerated dystrophy and decay of oligodendrocyte precursor cells in the app/ps1 model of alzheimer’s-like pathology
topic Cellular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744306/
https://www.ncbi.nlm.nih.gov/pubmed/33343301
http://dx.doi.org/10.3389/fncel.2020.575082
work_keys_str_mv AT chacondelarochairene accelerateddystrophyanddecayofoligodendrocyteprecursorcellsintheappps1modelofalzheimerslikepathology
AT fryattgemma accelerateddystrophyanddecayofoligodendrocyteprecursorcellsintheappps1modelofalzheimerslikepathology
AT riveraandread accelerateddystrophyanddecayofoligodendrocyteprecursorcellsintheappps1modelofalzheimerslikepathology
AT verkhratskyalexei accelerateddystrophyanddecayofoligodendrocyteprecursorcellsintheappps1modelofalzheimerslikepathology
AT raineteauolivier accelerateddystrophyanddecayofoligodendrocyteprecursorcellsintheappps1modelofalzheimerslikepathology
AT gomeznicoladiego accelerateddystrophyanddecayofoligodendrocyteprecursorcellsintheappps1modelofalzheimerslikepathology
AT buttarthurm accelerateddystrophyanddecayofoligodendrocyteprecursorcellsintheappps1modelofalzheimerslikepathology